WallStreetZenWallStreetZen

NASDAQ: XLO
Xilio Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Xilio Therapeutics revenue was $43.77M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $13.7M, down 28.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, XLO annual revenue was $43.8M, with 589.9% growth year-over-year.

XLO past revenue growth

How has XLO's revenue growth performed historically?

Company
589.88%
Industry
466.16%
Market
89.29%
XLO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
XLO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
XLO's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

XLO revenue history

Current Revenue
$43.8M
Current Earnings
-$35.0M
Current Profit Margin
-80.1%

Be the first to know when XLO announces revenue.

XLO Revenue History By Year

XLO Yearly RevenueXLO RevenueXLO ChangeXLO Revenue Growth
2025-12-31$43.77M$37.42M+589.88%
2024-12-31$6.34MN/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A

1 of 1

Xilio Therapeutics Revenue FAQ

What was XLO's revenue last quarter?

On Invalid Date, Xilio Therapeutics (NASDAQ: XLO) reported Q4 2025 revenue of $13.69 million up 693.85% year over year. In the same quarter last year, Xilio Therapeutics's revenue was $1.72 million.

What was Xilio Therapeutics's revenue in 2025?

Xilio Therapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $43.77 million, a 589.88% increase year over year.

How much does Xilio Therapeutics make in a day?

Based on Xilio Therapeutics annual revenue for the past five years, XLO makes an average of $27,457.53 per day.

What was Xilio Therapeutics's annual revenue growth in the past year?

As of Q2 2026, Xilio Therapeutics's revenue has grown 589.88% year over year. This is 123.72 percentage points higher than the US Biotechnology industry revenue growth rate of 466.16%. Xilio Therapeutics's revenue in the past year totaled $43.77 million.

How much does Xilio Therapeutics make in a year?

Xilio Therapeutics's revenue by year for the past five years is:
  • Xilio Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $43.77 million, a 589.88% increase year over year.
  • Xilio Therapeutics's annual revenue for Dec 31, 2024 was $6.34 million, a Infinity% increase from 2023.
  • Xilio Therapeutics's annual revenue for 2023 was $0.00, a N/A decrease from 2022.
  • Xilio Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Xilio Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.